CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Which Index Funds Have The Lowest Fees highlights cost-conscious choices for investors. Learn criteria to compare funds and choose low-fee options.
27,055 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Bitcoin stabilizes after a volatile week, signaling a potential turn for BTC as investors eye SpaceX's blockbuster IP...
New Federal Reserve data shows the average retirement stash sits around $333,940, but the median remains far lower, u...
A Parabilis Medicines director recently disclosed a substantial stake just after the company’s fresh IPO. This articl...
Meta Platforms is advancing Arena, a stand-alone prediction markets app that would start with non-cash points and cou...
Two former NBA players, Malik Beasley and Ed Davis, were named in a Brooklyn indictment tied to a large betting schem...
The U.S. has removed foreign-access restrictions on Anthropic’s Claude 3.5 and Fable 5, signaling a renewed AI leader...
Oil traffic through the Hormuz Strait shows signs of stabilization, with several tankers choosing an Oman-side route ...
Vertex’s $10 billion cash bid for Crinetics sparked a sharp rally, lifting the stock nearly to the offer price as tra...
Microsoft Copilot AI signals a bold XRP rally by year-end 2026, driven by real-world catalysts and on-chain activity....
Pi Network's Core Team rolled out a major redesign of the mining app and Pioneer profile page, promising clearer navi...
A leading XRPL validator announced opposition to additional reserve reductions, reviving a divide in the community ov...